Abstract

Background and Objectives: The use of the dopamine-partial agonist subclass (also termed dopamine stabilizers) of atypical antipsychotics for the treatment of negative schizophrenia symptoms and some mood disorders has increased recently. Similar to other second-generation antipsychotics (SGAs), aripiprazole (ARI) and cariprazine (CAR) also influence food intake, but the peripheral effects of these drugs on adipose–tissue homeostasis, including adipokine secretion as well as lipo- and adipogenesis, are not fully elucidated. In this study, we explored the adipocyte-related mechanisms induced by second-generation antipsychotics (SGAs), leading to changes in peripheral signals involved in energy homeostasis. Materials and Methods: CAR, a new SGA, was compared with ARI and olanzapine (OLA), using cell cultures to study adipogenesis, and the expression levels of peroxisome proliferator-activated receptor-γ (PPAR-γ) was measured in adipocytes derived from mouse fibroblasts, by western blotting on days 7, 14, and 21 postinduction. The triglyceride (TG) content of the cells was also evaluated on day 15 using Oil Red O staining, and the adiponectin (AN) content in the cell culture supernatants was quantified on days 7 and 15 by enzyme-linked immunosorbent assay. Cells were treated with two concentrations of ARI (0.5 and 20 µg/mL), OLA (1 and 20 µg/mL), and CAR (0.1 and 2 µg/mL). Results: Both concentrations of ARI and OLA, as well as the lower concentration of CAR, significantly increased the TG contents. The AN levels in the supernatants were significantly increased by the higher concentration of ARI on days 7 and 15 (p < 0.05). Although PPAR-γ levels were not significantly affected by ARI and OLA, the lower concentration of CAR induced a significant time-dependent decrease in PPAR-γ expression (p < 0.05). Conclusions: The in vitro adipogenesis considered from TG accumulation, AN secretion, and PPAR-γ expression was differently influenced by ARI, CAR, and OLA. Understanding the adipocyte-related mechanisms of antipsychotics could contribute to understanding their weight-influencing effect.

Highlights

  • Second-generation antipsychotics (SGAs) include newer agents used in the treatment of several psychiatric diseases, and are considered to be different from older drugs

  • Our results showed that these compounds had important effects on TG contents and peroxisome proliferator-activated receptor-γ (PPAR-γ) expression in adipocytes

  • ARI and CAR share some pharmacological targets and mechanisms involved in the antipsychotic action, they affected the in vitro induced adipogenesis in mouse fibroblast cells differently: ARI induced TG accumulation, increased AN concentration in culture supernatants, and did not change peroxisome proliferator-activated receptor (PPAR)-γ expression; while CAR induced TG accumulation, did not change AN concentrations, and decreased PPAR-γ expression

Read more

Summary

Introduction

Second-generation antipsychotics (SGAs) include newer agents used in the treatment of several psychiatric diseases, and are considered to be different from older drugs ( called classical or typical antipsychotics). These agents are thought to be more favorable in terms of efficacy and side effects; for example, SGAs do not induce the characteristic extrapyramidal side effects (EPS) and are more effective in treating the negative signs of schizophrenia [1,2,3,4]. Similar to other second-generation antipsychotics (SGAs), aripiprazole (ARI) and cariprazine (CAR) influence food intake, but the peripheral effects of these drugs on adipose–tissue homeostasis, including adipokine secretion as well as lipo- and adipogenesis, are not fully elucidated. The AN levels in the supernatants were significantly increased by the higher concentration of ARI on days 7 and

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call